Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

8
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
8
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

7
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
7
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

4.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.2K
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

11
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
11
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: Non-culprit plaque rupture in STEMI - marker of vulnerability or actionable risk?

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Longitudinal assessment of thrombin generation using calibrated automated thrombography in patients with continuous-flow left ventricular assist devices over a five-year period.

Scientific reports·2026
Same author

Recommendations for hypolipidemic and antithrombotic therapy in HCV-infected patients treated with direct-acting antiviral agents: expert position statement.

Clinical and experimental hepatology·2026
Same author

Clinical outcomes and missed benefits related to clopidogrel overuse in acute coronary syndrome.

Journal of thrombosis and thrombolysis·2026
Same author

Mortality score in chronic coronary syndrome: prediction model from the ISCHEMIA trial.

European journal of preventive cardiology·2026
Same author

Clinical utility of anthropometric parameters in identifying glucose dysregulation in women with polycystic ovary syndrome.

Frontiers in endocrinology·2026

Related Experiment Video

Updated: Apr 21, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

942

Amiodarone-related thyroid dysfunction.

Bartosz Hudzik1, Barbara Zubelewicz-Szkodzinska

  • 1Third Department of Cardiology, Silesian Centre for Heart Disease, Medical University of Silesia, Curie-Sklodowska 9, 41-800, Zabrze, Poland, bartekh@mp.pl.

Internal and Emergency Medicine
|October 29, 2014
PubMed
Summary

Amiodarone effectively treats dysrhythmias but can cause thyroid issues. Awareness and multidisciplinary discussion are crucial for managing these risks, especially with alternatives like dronedarone.

More Related Videos

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

1.3K
Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

22.2K

Related Experiment Videos

Last Updated: Apr 21, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

942
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

1.3K
Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

22.2K

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Amiodarone is a widely used antiarrhythmic drug for various dysrhythmias.
  • It is effective and well-tolerated in patients with varying cardiac function.
  • However, amiodarone is associated with significant adverse effects, particularly on the thyroid gland.

Purpose of the Study:

  • To highlight the prevalence and importance of amiodarone-induced thyroid dysfunction.
  • To discuss the challenges in managing amiodarone's side effects.
  • To compare amiodarone with alternatives like dronedarone, considering their respective risks.

Main Methods:

  • Review of clinical practice and existing literature on amiodarone and dronedarone.
  • Analysis of adverse effect profiles and patient outcomes.
  • Discussion of diagnostic and therapeutic strategies for amiodarone-related thyroid issues.

Main Results:

  • Amiodarone remains a primary treatment for dysrhythmias despite its adverse effects.
  • Thyroid dysfunction is a common and significant concern with amiodarone use.
  • Dronedarone presents alternative risks, including hepatic injury and increased mortality in specific patient groups.

Conclusions:

  • Physicians and patients must be aware of amiodarone's thyroid-specific adverse effects.
  • Multidisciplinary collaboration among patients, general practitioners, cardiologists, and endocrinologists is essential for optimal management.
  • Careful consideration of risks and benefits is necessary when choosing between amiodarone and newer agents like dronedarone.